("IFEC"), with the assistance or facilitation of T&S Inter Product Life Company Limited ("T&S"), Mr. Pannawit Jaturapornsawat who is an authorized director of T&S and Mr
;IFEC"), with the assistance or facilitation of T&S Inter Product Life Company Limited ("T&S"), Mr. Pannawit Jaturapornsawat who is an authorized director of T&S and Mr
offered securities; nor contain any assurance in relation to the value or returns on the offered securities; nor shall they certify the accuracy and completeness of information contained in the registration
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the
Subsidiary RTN Insurance Broker Company Limited RTN Insurance Broker Company Limited which is principally engaged in life and non-life insurance brokerages and start operation during in the first quarter of
percent of the h the value nths, the total - Translation x Insurance (T 8 of JMT Ne assed a resolu ny Limited (“P of the transa oenix Insuran on-Life Insuran 2,000,000 Ba 2,000,000 Ba e Company w sting